Auditory Neuropathy: Challenges and Significant Progress in Diagnosis and Treatment
Advanced Therapeutics · 2026-03 · 9 (3)
DOI: 10.1002/adtp.202500513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Therapeutics, online erschienen am 28.02.2026. Verfasst von Wen Xie und 11 weiteren Autor:innen. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Karolinska Institutet.
Abstract (Originalsprache)
Auditory neuropathy (AN) is a complex disorder where sensorineural hearing impairment occurs due to abnormal neural encoding to sound stimuli. This can be caused by damage to sensory inner hair cells (IHCs)‐presynapse, IHC ribbon synapses, or spiral ganglion neurons via post‐synapse. Genetic factors play a significant role in AN. Audiological assessment such as otoacoustic emissions, auditory brainstem responses, and speech audiometry is crucial in diagnosing auditory neuropathy. Hearing aids and cochlear implants are currently commonly used methods for interventing AN. Owing to the intricate nature of the disease's pathogenesis, a standardized diagnostic approach has yet to be established, and therapeutic options remain significantly constrained. However, it is noteworthy that breakthrough progress has been made in the treatment of AN. In 2024, Chinese researchers used adeno‐associated virus gene therapy for AN patients with OTOF gene mutations, and achieved exceptionally good results in clinical trials. This review focuses on auditory neuropathy, covering its theoretical foundations, epidemiology, diagnostic techniques, treatment strategies, clinical practice, as well as future directions and controversie.
Förderung
- National Key Research and Development Program of China
- Karolinska Institutet
Zitieren
APA
Xie, W., Lu, L., Tong, B., Fang, L., Dai, Q., Chen, X., Qi, J., Qian, X., Gao, X., Chai, R., Yang, J., & Duan, M. (2026). Auditory Neuropathy: Challenges and Significant Progress in Diagnosis and Treatment. Advanced Therapeutics, 9(3). https://doi.org/10.1002/adtp.202500513
Vancouver
Xie W, Lu L, Tong B, Fang L, Dai Q, Chen X, et al. Auditory Neuropathy: Challenges and Significant Progress in Diagnosis and Treatment. Advanced Therapeutics. 2026;9(3). doi:10.1002/adtp.202500513
BibTeX
@article{Xie2026,
author = {Xie, Wen and Lu, Ling and Tong, Busheng and Fang, Lian and Dai, Qingqing and Chen, Xiaowan and Qi, Jieyu and Qian, Xiaoyun and Gao, Xia and Chai, Renjie and Yang, Jun and Duan, Maoli},
title = {Auditory Neuropathy: Challenges and Significant Progress in Diagnosis and Treatment},
journal = {Advanced Therapeutics},
year = {2026},
volume = {9},
number = {3},
doi = {10.1002/adtp.202500513}
}
EUVIMED